Delivery Order 75N93023D00001-75N93024F00004
Award Date 7/1/24
Potential Completion Date 6/30/25
Potential Value $253K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
- This is a $6,095,159.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for expertise in professional pharmaceutical project management. The contract is issued under the larger Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a manufacturer of biologics including vaccines and monoclonal antibodies,...
- This is a $3,500 firm-fixed-price delivery order awarded to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health. The order is under the NIAID's Diagnostics Pre-Clinical Services Program Indefinite Delivery Vehicle (IDV), which has a total ceiling value of $24 million. ABL, a foreign-owned, for-profit manufacturer, is providing a range of preclinical development services to support...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $4,709,463.34, is for NIAID's Preclinical Development Support program focused on the immunoaffinity purification of HIV-1 envelope proteins. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. This award does not have a...
- The federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit organization that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract, with a ceiling value of $2,745,187.57, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is a Delivery Order with a...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for the provision of expertise in ethnographic research related to the enhancement of study drug adherence and uptake in human immunodeficiency virus (HIV) prevention trials. The contract has a ceiling value of...
- This federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) is for the cGMP manufacturing of a glycopeptide immunogen nanoparticle vaccine in support of preclinical development activities for the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $4,683,305.11 cost-plus-fixed-fee contract has a period of performance through December 31, 2025. ABL, a for-profit manufacturer of goods, will provide a range of...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development...
- This is a prime contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on September 20, 2017. The contract has a potential value of $2,044,103.00 and is a Delivery Order for NIAID Preclinical Development Support services. The contract has a completion date of December 31, 2022 and is not set-aside. ABL is a contract research and...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), is valued at $79,489.53. The contract was awarded to the prime contractor, Advanced Bioscience Laboratories, Inc. (ABL), to assist NIAID in planning and implementing two consultations focused on quality management systems and quality risk management for NIAID contractors and extramural programmatic staff. The contract has no set-aside...